Global Prescription Dermatological Drugs Market Analysis 2016-2020 and Forecast 2021-2026
Global Prescription Dermatological Drugs Market Analysis 2016-2020 and Forecast 2021-2026
The Global Prescription Dermatological Drugs Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like Johnson & Johnson , Merck , Bayer , Mylan Pharmaceuticals , Pfizer , F. Hoffmann-La Roche , Allergan , Valeant Pharmaceuticals , PharmaDerm Pharmaceuticals , Allergan Inamed Corporation
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Prescription Dermatological Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Prescription Dermatological Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Anti-acne Drugs
Anti-aging Drugs
Dermatitis Drugs
Hair Loss Drugs
Psoriasis Drugs
Skin Cancer Drugs
Melasma Drugs
Seborrhea Drugs
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Johnson & Johnson
Merck
Bayer
Mylan Pharmaceuticals
Pfizer
F. Hoffmann-La Roche
Allergan
Valeant Pharmaceuticals
PharmaDerm Pharmaceuticals
Allergan Inamed Corporation
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Prescription Dermatological Drugs Industry
Figure Prescription Dermatological Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Prescription Dermatological Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Prescription Dermatological Drugs
1.2.2 Downstream
Table Application Segment of Prescription Dermatological Drugs
Table Global Prescription Dermatological Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Prescription Dermatological Drugs Market by Type
3.1 By Type
3.1.1 Anti-acne Drugs
Table Major Company List of Anti-acne Drugs
3.1.2 Anti-aging Drugs
Table Major Company List of Anti-aging Drugs
3.1.3 Dermatitis Drugs
Table Major Company List of Dermatitis Drugs
3.1.4 Hair Loss Drugs
Table Major Company List of Hair Loss Drugs
3.1.5 Psoriasis Drugs
Table Major Company List of Psoriasis Drugs
3.1.6 Skin Cancer Drugs
Table Major Company List of Skin Cancer Drugs
3.1.7 Melasma Drugs
Table Major Company List of Melasma Drugs
3.1.8 Seborrhea Drugs
Table Major Company List of Seborrhea Drugs
3.2 Market Size
Table Global Prescription Dermatological Drugs Market 2016-2020, by Type, in USD Million
Figure Global Prescription Dermatological Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Prescription Dermatological Drugs Market 2016-2020, by Type, in Volume
Figure Global Prescription Dermatological Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Prescription Dermatological Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Prescription Dermatological Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Johnson & Johnson (Company Profile, Sales Data etc.)
4.1.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.1.2 Johnson & Johnson Products & Services
4.1.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Merck (Company Profile, Sales Data etc.)
4.2.1 Merck Profile
Table Merck Overview List
4.2.2 Merck Products & Services
4.2.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bayer (Company Profile, Sales Data etc.)
4.3.1 Bayer Profile
Table Bayer Overview List
4.3.2 Bayer Products & Services
4.3.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Mylan Pharmaceuticals (Company Profile, Sales Data etc.)
4.4.1 Mylan Pharmaceuticals Profile
Table Mylan Pharmaceuticals Overview List
4.4.2 Mylan Pharmaceuticals Products & Services
4.4.3 Mylan Pharmaceuticals Business Operation Conditions
Table Business Operation of Mylan Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Pfizer (Company Profile, Sales Data etc.)
4.5.1 Pfizer Profile
Table Pfizer Overview List
4.5.2 Pfizer Products & Services
4.5.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
4.6.1 F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Overview List
4.6.2 F. Hoffmann-La Roche Products & Services
4.6.3 F. Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Allergan (Company Profile, Sales Data etc.)
4.7.1 Allergan Profile
Table Allergan Overview List
4.7.2 Allergan Products & Services
4.7.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Valeant Pharmaceuticals (Company Profile, Sales Data etc.)
4.8.1 Valeant Pharmaceuticals Profile
Table Valeant Pharmaceuticals Overview List
4.8.2 Valeant Pharmaceuticals Products & Services
4.8.3 Valeant Pharmaceuticals Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 PharmaDerm Pharmaceuticals (Company Profile, Sales Data etc.)
4.9.1 PharmaDerm Pharmaceuticals Profile
Table PharmaDerm Pharmaceuticals Overview List
4.9.2 PharmaDerm Pharmaceuticals Products & Services
4.9.3 PharmaDerm Pharmaceuticals Business Operation Conditions
Table Business Operation of PharmaDerm Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Allergan Inamed Corporation (Company Profile, Sales Data etc.)
4.10.1 Allergan Inamed Corporation Profile
Table Allergan Inamed Corporation Overview List
4.10.2 Allergan Inamed Corporation Products & Services
4.10.3 Allergan Inamed Corporation Business Operation Conditions
Table Business Operation of Allergan Inamed Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Prescription Dermatological Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Prescription Dermatological Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Prescription Dermatological Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Prescription Dermatological Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Prescription Dermatological Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Prescription Dermatological Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Prescription Dermatological Drugs Market Concentration, in 2020
Figure Europe Prescription Dermatological Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Prescription Dermatological Drugs MMarket Concentration, in 2020
Figure South America Prescription Dermatological Drugs Market Concentration, in 2020
Figure Middle East & Africa Prescription Dermatological Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies
Figure Prescription Dermatological Drugs Demand in Hospital Pharmacies , 2016-2020, in USD Million
Figure Prescription Dermatological Drugs Demand in Hospital Pharmacies , 2016-2020, in Volume
6.1.2 Demand in Retail Pharmacies
Figure Prescription Dermatological Drugs Demand in Retail Pharmacies , 2016-2020, in USD Million
Figure Prescription Dermatological Drugs Demand in Retail Pharmacies , 2016-2020, in Volume
6.1.3 Demand in Online Pharmacies
Figure Prescription Dermatological Drugs Demand in Online Pharmacies, 2016-2020, in USD Million
Figure Prescription Dermatological Drugs Demand in Online Pharmacies, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Prescription Dermatological Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Prescription Dermatological Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Prescription Dermatological Drugs Market Share in 2026, by Application, in USD Million
Table Prescription Dermatological Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Prescription Dermatological Drugs Market Growth 2021-2026, by Application, in Volume
Table Prescription Dermatological Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Prescription Dermatological Drugs Production 2016-2020, by Region, in USD Million
Table Prescription Dermatological Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Prescription Dermatological Drugs Market 2016-2020, by Region, in USD Million
Table Global Prescription Dermatological Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Prescription Dermatological Drugs Market 2016-2020, by Region, in Volume
Table Global Prescription Dermatological Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Prescription Dermatological Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Prescription Dermatological Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Research Methodology:
Prescription Dermatological Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|